International Biotechnology Trust PLC Amylyx Pharmaceuticals, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 295,000 shares of AMLX stock, worth $1.12 Million. This represents 1.83% of its overall portfolio holdings.
Number of Shares
295,000
Previous 25,000
1080.0%
Holding current value
$1.12 Million
Previous $539,000
902.04%
% of portfolio
1.83%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding AMLX
# of Institutions
141Shares Held
48.9MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$25.6 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$17.6 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$10.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$10.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$9.17 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $221M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...